AMA News reports a Wall Street Journal analysis: Price increases by drug makers exceed inflation
A front-page analysis in the Wall Street Journal (10/6, A1, Walker, Subscription Publication) examines the ability of pharmaceutical companies to boost their revenue by increasing drug prices beyond the rate of inflation regardless of the level of demand for the medicines. The Journal analysis found that US revenue growth from the 30 top-selling drugs sold in pharmacies has exceeded demand for the past five years.
AMA News_ October, 2015.